To investigate the effects of Gal9 on glioma survival, we collected 325 glioma patients (included 144 GBM patients) from the CGGA database and 676 glioma patients (included 539 GBM patients) from the TCGA database. This evidence concerns the gene LGALS9 and central nervous system cancer.